Cited by 9Enzyme Structure and FunctionProtease and Inhibitor MechanismsPeptidase Inhibition and Analysis

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Structure of puromycin-sensitive aminopeptidase and polyglutamine binding

Open access

Published version of a preprint

Abstract

Puromycin-sensitive aminopeptidase (E.C. 3.4.11.14, UniProt P55786), a zinc metallopeptidase belonging to the M1 family, degrades a number of bioactive peptides as well as peptides released from the proteasome, including polyglutamine. We report the crystal structure of PSA at 2.3 Ǻ. Overall, the enzyme adopts a V-shaped architecture with four domains characteristic of the M1 family aminopeptidases, but it is in a less compact conformation compared to most M1 enzymes of known structure. A microtubule binding sequence is present in a C-terminal HEAT repeat domain of the enzyme in a position where it might serve to mediate interaction with tubulin. In the catalytic metallopeptidase domain, an elongated active site groove lined with aromatic and hydrophobic residues and a large S1 subsite may play a role in broad substrate recognition. The structure with bound polyglutamine shows a possible interacting mode of this peptide, which is supported by mutation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0287086

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 113

  1. GM Littlewood, 1988, Neuropeptides and their peptidases: functional considerations, Neurochem Int, 12, 383, 10.1016/0197-0186(88)90178-7 · DOI
  2. CS Konkoy, 1996, Ectoenzymes as sites of peptide regulation., Trends in Pharmaceutical Sciences, 17, 288, 10.1016/0165-6147(96)10036-5 · DOI
  3. JF McKelvy, 1986, Inactivation and metabolism of neuropeptides, Annual Review of Neuroscience, 9, 415, 10.1146/annurev.ne.09.030186.002215 · DOI
  4. ND Rawlings, 1995, Evolutionary families of metallopeptidases, Methods in Enzymology, 248, 183, 10.1016/0076-6879(95)48015-3 · DOI
  5. AL Albiston, 2004, Membrane bound members of the M1 family: more than aminopeptidases, Protein Pept Lett, 11, 491, 10.2174/0929866043406643 · DOI
  6. D. Mantle, 1992, Comparison of soluble aminopeptidases in human cerebral cortex, skeletal muscle and kidney tissues, Clin Chim Acta, 207, 107, 10.1016/0009-8981(92)90154-I · DOI
  7. LB Hersh, 1981, An aminopeptidase from bovine brain which catalyzes the hydrolysis of enkephalin, J Neurochem, 36, 171, 10.1111/j.1471-4159.1981.tb02392.x · DOI
  8. LB Hersh, 1980, Cleavage of endorphins to des-Tyr endorphins by homogeneous bovine brain aminopeptidase, Nature, 286, 160, 10.1038/286160a0 · DOI
  9. A Safavi, 1995, Degradation of dynorphin-related peptides by the puromycin-sensitive aminopeptidase and aminopeptidase M, J Neurochem, 65, 389, 10.1046/j.1471-4159.1995.65010389.x · DOI
  10. DB Constam, 1995, Puromycin-sensitive aminopeptidase. Sequence analysis, expression, and functional characterization, Journal of Biologial Chemistry, 270, 26931
  11. WA Peer, 2011, The role of multifunctional M1 metallopeptidases in cell cycle progression, Ann Bot, 107, 1171, 10.1093/aob/mcq265 · DOI
  12. SM Fortin, 2010, The PAM-1 aminopeptidase regulates centrosome positioning to ensure anterior-posterior axis specification in one-cell C. elegans embryos, Dev Biol, 344, 992, 10.1016/j.ydbio.2010.06.016 · DOI
  13. DM Saturno, 2017, Sustained centrosome-cortical contact ensures robust polarization of the one-cell C. elegans embryo, Dev Biol, 422, 135, 10.1016/j.ydbio.2016.12.025 · DOI
  14. S Osana, 2021, Puromycin-sensitive aminopeptidase is required for C2C12 myoblast proliferation and differentiation, J Cell Physiol, 236, 5293, 10.1002/jcp.30237 · DOI
  15. D Benton, 2021, Interactions between the WEE-1.3 kinase and the PAM-1 aminopeptidase in oocyte maturation and the early C. elegans embryo., G3 (Bethesda)., 11, 10.1093/g3journal/jkab063 · DOI
  16. N Agrawal, 2014, Genetic associations and functional characterization of M1 aminopeptidases and immune-mediated diseases, Genes Immun, 15, 521, 10.1038/gene.2014.46 · DOI
  17. B Lowenberg, 2010, Phase I/II clinical study of Tosedostat, an inhibitor of aminopeptidases, in patients with acute myeloid leukemia and myelodysplasia, J Clin Oncol, 28, 4333, 10.1200/JCO.2009.27.6295 · DOI
  18. R Singh, 2017, Puromycin based inhibitors of aminopeptidases for the potential treatment of hematologic malignancies, Eur J Med Chem, 139, 325, 10.1016/j.ejmech.2017.07.048 · DOI
  19. T Osada, 2001, Male reproductive defects caused by puromycin-sensitive aminopeptidase deficiency in mice, Mol Endocrinol, 15, 960, 10.1210/mend.15.6.0643 · DOI
  20. T Osada, 2001, Puromycin-sensitive aminopeptidase is essential for the maternal recognition of pregnancy in mice, Mol Endocrinol, 15, 882, 10.1210/mend.15.6.0644 · DOI
  21. R Lyczak, 2006, The puromycin-sensitive aminopeptidase PAM-1 is required for meiotic exit and anteroposterior polarity in the one-cell Caenorhabditis elegans embryo, Development, 133, 4281, 10.1242/dev.02615 · DOI
  22. DR Brooks, 2003, The Caenorhabditis elegans orthologue of mammalian puromycin-sensitive aminopeptidase has roles in embryogenesis and reproduction, Journal of Biologial Chemistry, 278, 42795, 10.1074/jbc.M306216200 · DOI
  23. C Schulz, 2001, Genetic analysis of dPsa, the Drosophila orthologue of puromycin-sensitive aminopeptidase, suggests redundancy of aminopeptidases, Dev Genes Evol, 211, 581, 10.1007/s00427-001-0194-z · DOI
  24. T Osada, 1999, Increased anxiety and impaired pain response in puromycin-sensitive aminopeptidase gene-deficient mice obtained by a mouse gene-trap method, Journal of Neuroscience, 19, 6068, 10.1523/JNEUROSCI.19-14-06068.1999 · DOI
  25. SL Karsten, 2006, A genomic screen for modifiers of tauopathy identifies puromycin-sensitive aminopeptidase as an inhibitor of tau-induced neurodegeneration, Neuron, 51, 549, 10.1016/j.neuron.2006.07.019 · DOI · Paper page
  26. S Sengupta, 2006, Degradation of tau protein by puromycin-sensitive aminopeptidase in vitro, Biochemistry, 45, 15111, 10.1021/bi061830d · DOI
  27. K Yanagi, 2009, Involvement of puromycin-sensitive aminopeptidase in proteolysis of tau protein in cultured cells, and attenuated proteolysis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) mutant tau., Psychogeriatrics, 9, 157, 10.1111/j.1479-8301.2010.00307.x · DOI
  28. LC Kudo, 2011, Puromycin-sensitive aminopeptidase (PSA/NPEPPS) impedes development of neuropathology in hPSA/TAU(P301L) double-transgenic mice., Hum Mol Genet, 20, 1820, 10.1093/hmg/ddr065 · DOI
  29. KM Chow, 2010, Aminopeptidases do not directly degrade tau protein., Mol Neurodegener, 5, 48, 10.1186/1750-1326-5-48 · DOI
  30. N Bhutani, 2007, Puromycin-sensitive aminopeptidase is the major peptidase responsible for digesting polyglutamine sequences released by proteasomes during protein degradation, EMBO Journal, 26, 1385, 10.1038/sj.emboj.7601592 · DOI
  31. FM Menzies, 2010, Puromycin-sensitive aminopeptidase protects against aggregation-prone proteins via autophagy, Hum Mol Genet, 19, 4573, 10.1093/hmg/ddq385 · DOI
  32. G Ren, 2011, Cu, Zn-superoxide dismutase 1 (SOD1) is a novel target of Puromycin-sensitive aminopeptidase (PSA/NPEPPS): PSA/NPEPPS is a possible modifier of amyotrophic lateral sclerosis., Mol Neurodegener, 6, 29, 10.1186/1750-1326-6-29 · DOI
  33. MW Thompson, 2003, Mutation of active site residues of the puromycin-sensitive aminopeptidase: conversion of the enzyme into a catalytically inactive binding protein, Arch, Biochem, Biophys, 413, 236, 10.1016/S0003-9861(03)00123-1 · DOI
  34. MW Thompson, 2003, Analysis of conserved residues of the human puromycin-sensitive aminopeptidase, Peptides, 24, 1359, 10.1016/j.peptides.2003.07.012 · DOI
  35. DW Rodgers, 1997, Practical Cryocrystallography., Methods Enzymol, 276, 183, 10.1016/S0076-6879(97)76059-2 · DOI
  36. Z Otwinowski, 1997, Processing of X-ray diffraction data collected in oscillation mode., Macromolecular Crystallography, Pt A., 276, 307, 10.1016/S0076-6879(97)76066-X · DOI · Paper page
  37. OJ Kyrieleis, 2005, Crystal structures of the tricorn interacting factor F3 from Thermoplasma acidophilum, a zinc aminopeptidase in three different conformations, Journal of Molecular Biology, 349, 787, 10.1016/j.jmb.2005.03.070 · DOI
  38. D Liebschner, 2019, Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix, Acta Crystallogr D Struct Biol, 75, 861, 10.1107/S2059798319011471 · DOI · Paper page
  39. PD Adams, 2010, PHENIX: a comprehensive Python-based system for macromolecular structure solution, Acta Crystallogr D Biol Crystallogr, 66, 213, 10.1107/S0907444909052925 · DOI · Paper page
  40. P Emsley, 2004, Coot: model-building tools for molecular graphics, Acta Crystallogr D Biol Crystallogr, 60, 2126, 10.1107/S0907444904019158 · DOI · Paper page
  41. S Chen, 2001, Solubilization and disaggregation of polyglutamine peptides, Protein Science, 10, 887, 10.1110/ps.42301 · DOI
  42. A Addlagatta, 2006, Structure of aminopeptidase N from Escherichia coli suggests a compartmentalized, gated active site, Proc Natl Acad Sci U S A, 103, 13339, 10.1073/pnas.0606167103 · DOI
  43. K Ito, 2006, Crystal structure of aminopeptidase N (proteobacteria alanyl aminopeptidase) from Escherichia coli and conformational change of methionine 260 involved in substrate recognition., Journal of Biologial Chemistry, 281, 33664, 10.1074/jbc.M605203200 · DOI
  44. S McGowan, 2009, Structural basis for the inhibition of the essential Plasmodium falciparum M1 neutral aminopeptidase, Proc Natl Acad Sci U S A, 106, 2537, 10.1073/pnas.0807398106 · DOI
  45. MM Thunnissen, 2001, Crystal structure of human leukotriene A(4) hydrolase, a bifunctional enzyme in inflammation, Nat Struct Biol, 8, 131, 10.1038/84117 · DOI
  46. G Kochan, 2011, Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming, Proc Natl Acad Sci U S A, 108, 7745, 10.1073/pnas.1101262108 · DOI
  47. TT Nguyen, 2011, Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1, Nat Struct Mol Biol, 18, 604, 10.1038/nsmb.2021 · DOI
  48. JR Birtley, 2012, The crystal structure of human endoplasmic reticulum aminopeptidase 2 reveals the atomic basis for distinct roles in antigen processing, Biochemistry, 51, 286, 10.1021/bi201230p · DOI
  49. MA Holmes, 1982, Structure of thermolysin refined at 1.6 A resolution, Journal of Molecular Biology, 160, 623, 10.1016/0022-2836(82)90319-9 · DOI
  50. MA Holmes, 1983, Structural analysis of the inhibition of thermolysin by an active-site-directed irreversible inhibitor, Biochemistry, 22, 236, 10.1021/bi00270a034 · DOI
  51. PM Colman, 1972, The structure of thermolysin: an electron density map at 2–3 A resolution, Journal of Molecular Biology, 70, 701, 10.1016/0022-2836(72)90569-4 · DOI
  52. BW Matthews, 1972, Structure of thermolysin, Nat New Biol, 238, 41, 10.1038/newbio238041a0 · DOI
  53. BW Matthews, 1972, Three-dimensional structure of thermolysin, Nat New Biol, 238, 37, 10.1038/newbio238037a0 · DOI
  54. BW Matthews, 1974, The conformation of thermolysin, Journal of Biologial Chemistry, 249, 8030, 10.1016/S0021-9258(19)42067-X · DOI
  55. ND Rawlings, 2004, MEROPS: the peptidase database, Nucleic Acids Research, 32, D160, 10.1093/nar/gkh071 · DOI
  56. MA Andrade, 2001, Comparison of ARM and HEAT protein repeats, Journal of Molecular Biology, 309, 1, 10.1006/jmbi.2001.4624 · DOI
  57. Z Ma, 2003, Proteolytic cleavage of the puromycin-sensitive aminopeptidase generates a substrate binding domain, Archives of Biochemistry and Biophysics, 415, 80, 10.1016/S0003-9861(03)00200-5 · DOI
  58. P Giastas, 2019, Mechanism for antigenic peptide selection by endoplasmic reticulum aminopeptidase 1, Proc Natl Acad Sci U S A, 116, 26709, 10.1073/pnas.1912070116 · DOI
  59. Z Maben, 2020, Discovery of Selective Inhibitors of Endoplasmic Reticulum Aminopeptidase 1, Journal of Medicinal Chemistry, 63, 103, 10.1021/acs.jmedchem.9b00293 · DOI
  60. Z Maben, 2021, Conformational dynamics linked to domain closure and substrate binding explain the ERAP1 allosteric regulation mechanism., Nat Commun, 12, 5302, 10.1038/s41467-021-25564-w · DOI
  61. H Kakuta, 2003, Fluorescent bioprobes for visualization of puromycin-sensitive aminopeptidase in living cells, Bioorg Med Chem Lett, 13, 83, 10.1016/S0960-894X(02)00845-4 · DOI
  62. H Aizawa, 1989, A common amino acid sequence in 190-kDa microtubule-associated protein and tau for the promotion of microtubule assembly, Journal of Biologial Chemistry, 264, 5885, 10.1016/S0021-9258(18)83632-8 · DOI
  63. H Kadavath, 2015, Tau stabilizes microtubules by binding at the interface between tubulin heterodimers, Proc Natl Acad Sci U S A, 112, 7501, 10.1073/pnas.1504081112 · DOI · Paper page
  64. L Dehmelt, 2005, The MAP2/Tau family of microtubule-associated proteins, Genome Biol, 6, 204, 10.1186/gb-2004-6-1-204 · DOI · Paper page
  65. RB Ravelli, 2004, Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain, Nature, 428, 198, 10.1038/nature02393 · DOI
  66. J Al-Bassam, 2007, Crystal structure of a TOG domain: conserved features of XMAP215/Dis1-family TOG domains and implications for tubulin binding, Structure, 15, 355, 10.1016/j.str.2007.01.012 · DOI
  67. P Ayaz, 2012, A TOG:alphabeta-tubulin complex structure reveals conformation-based mechanisms for a microtubule polymerase, Science, 337, 857, 10.1126/science.1221698 · DOI
  68. JB Leano, 2013, A cryptic TOG domain with a distinct architecture underlies CLASP-dependent bipolar spindle formation, Structure, 21, 939, 10.1016/j.str.2013.04.018 · DOI
  69. GJ Brouhard, 2014, The contribution of alphabeta-tubulin curvature to microtubule dynamics, Journal of Cell Biology, 207, 323, 10.1083/jcb.201407095 · DOI
  70. M Groll, 1997, Structure of 20S proteasome from yeast at 2.4 A resolution., Nature, 386, 463, 10.1038/386463a0 · DOI
  71. Y Yang, 2013, Structural insights into central hypertension regulation by human aminopeptidase A, Journal of Biologial Chemistry, 288, 25638, 10.1074/jbc.M113.494955 · DOI
  72. AH Wong, 2012, The X-ray crystal structure of human aminopeptidase N reveals a novel dimer and the basis for peptide processing, Journal of Biologial Chemistry, 287, 36804, 10.1074/jbc.M112.398842 · DOI
  73. L Chen, 2012, Structural basis for multifunctional roles of mammalian aminopeptidase N, Proc Natl Acad Sci U S A, 109, 17966, 10.1073/pnas.1210123109 · DOI
  74. J Reguera, 2012, Structural bases of coronavirus attachment to host aminopeptidase N and its inhibition by neutralizing antibodies., PLoS Pathog, 8, e1002859, 10.1371/journal.ppat.1002859 · DOI
  75. SC Atkinson, 2015, The Anopheles-midgut APN1 structure reveals a new malaria transmission-blocking vaccine epitope, Nat Struct Mol Biol, 22, 532, 10.1038/nsmb.3048 · DOI
  76. SJ Hermans, 2015, Crystal structure of human insulin-regulated aminopeptidase with specificity for cyclic peptides, Protein Science, 24, 190, 10.1002/pro.2604 · DOI
  77. A Mpakali, 2015, Crystal Structure of Insulin-Regulated Aminopeptidase with Bound Substrate Analogue Provides Insight on Antigenic Epitope Precursor Recognition and Processing, J Immunol, 195, 2842, 10.4049/jimmunol.1501103 · DOI
  78. C Bauvois, 2008, Crystal structure of the cold-active aminopeptidase from Colwellia psychrerythraea, a close structural homologue of the human bifunctional leukotriene A4 hydrolase., Journal of Biologial Chemistry, 283, 23315, 10.1074/jbc.M802158200 · DOI
  79. AK Marapaka, 2018, Discovery, Structural and Biochemical Studies of a rare Glu/Asp Specific M1 Class Aminopeptidase from Legionella pneumophila, Int J Biol Macromol, 120, 1111, 10.1016/j.ijbiomac.2018.08.172 · DOI
  80. R Agrawal, 2020, Structural basis for the unusual substrate specificity of unique two-domain M1 metallopeptidase, Int J Biol Macromol, 147, 304, 10.1016/j.ijbiomac.2019.12.239 · DOI
  81. R Agrawal, 2019, Two-domain aminopeptidase of M1 family: Structural features for substrate binding and gating in absence of C-terminal domain, J Struct Biol, 208, 51, 10.1016/j.jsb.2019.07.010 · DOI
  82. A Mpakali, 2017, Ligand-Induced Conformational Change of Insulin-Regulated Aminopeptidase: Insights on Catalytic Mechanism and Active Site Plasticity, Journal of Medicinal Chemistry, 60, 2963, 10.1021/acs.jmedchem.6b01890 · DOI
  83. M Varadi, 2022, AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models, Nucleic Acids Res, 50, D439, 10.1093/nar/gkab1061 · DOI · Paper page
  84. W Tian, 2018, CASTp 3.0: computed atlas of surface topography of proteins, Nucleic Acids Res, 46, W363, 10.1093/nar/gky473 · DOI · Paper page
  85. X Iturrioz, 2001, Study of asparagine 353 in aminopeptidase A: characterization of a novel motif (GXMEN) implicated in exopeptidase specificity of monozinc aminopeptidases, Biochemistry, 40, 14440, 10.1021/bi011409j · DOI
  86. G Vazeux, 1998, A glutamate residue contributes to the exopeptidase specificity in aminopeptidase A, Biochemical Journal, 334, 407, 10.1042/bj3340407 · DOI
  87. E Cattaneo, 2005, Normal huntingtin function: an alternative approach to Huntington’s disease., Nat Rev Neurosci, 6, 919, 10.1038/nrn1806 · DOI
  88. HY Zoghbi, 2000, Glutamine repeats and neurodegeneration, Annu Rev Neurosci, 23, 217, 10.1146/annurev.neuro.23.1.217 · DOI
  89. E Scherzinger, 1999, Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington’s disease pathology, Proc Natl Acad Sci U S A, 96, 4604, 10.1073/pnas.96.8.4604 · DOI
  90. SW Davies, 1997, Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation, Cell, 90, 537, 10.1016/S0092-8674(00)80513-9 · DOI
  91. P Venkatraman, 2004, Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins, Mol Cell, 14, 95, 10.1016/S1097-2765(04)00151-0 · DOI
  92. HP Schnebli, 1979, Isolation and characterization of an enkephalin-degrading aminopeptidase from rat brain, Biochemica Biophysica Acta, 569, 89, 10.1016/0005-2744(79)90084-6 · DOI
  93. GW Wagner, 1981, Purification and characterization of an enkephalin aminopeptidase from rat brain, Biochemistry, 20, 3884, 10.1021/bi00516a034 · DOI
  94. E Sanchez-Moran, 2004, A puromycin-sensitive aminopeptidase is essential for meiosis in Arabidopsis thaliana, Plant Cell, 16, 2895, 10.1105/tpc.104.024992 · DOI
  95. SL Klein, 2002, Genetic and genomic tools for Xenopus research: The NIH Xenopus initiative, Dev Dyn, 225, 384, 10.1002/dvdy.10174 · DOI
  96. N Tamura, 1998, The role of tricorn protease and its aminopeptidase-interacting factors in cellular protein degradation, Cell, 95, 637, 10.1016/S0092-8674(00)81634-7 · DOI
  97. D Chandu, 2003, PepN, the major Suc-LLVY-AMC-hydrolyzing enzyme in Escherichia coli, displays functional similarity with downstream processing enzymes in Archaea and eukarya. Implications in cytosolic protein degradation., Journal of Biologial Chemistry, 278, 5548, 10.1074/jbc.M207926200 · DOI
  98. KS Hui, 1988, Major rat brain membrane-associated and cytosolic enkephalin-degrading aminopeptidases: comparison studies, J Neurosci Res, 20, 231, 10.1002/jnr.490200212 · DOI
  99. JR McDermott, 1985, Purification and characterization of a neuropeptide-degrading aminopeptidase from human brain, J Neurochem, 45, 752, 10.1111/j.1471-4159.1985.tb04056.x · DOI
  100. S McLellan, 1988, Studies on the tissue distribution of the puromycin-sensitive enkephalin-degrading aminopeptidases, J Neurochem, 51, 1552, 10.1111/j.1471-4159.1988.tb01124.x · DOI
  101. AC Camargo, 1994, Structural requirements of bioactive peptides for interaction with endopeptidase 22.19, Neuropeptides, 26, 281, 10.1016/0143-4179(94)90083-3 · DOI
  102. ACM Camargo, 1997, Structural features that make oligopeptides susceptible substrates for hydrolysis by recombinant thimet oligopeptidase, Biochemical Journal, 324, 517, 10.1042/bj3240517 · DOI
  103. E Csuhai, 1998, Proteolytic and Cellular Mechanisms in Prohormone and Neuropeptide Precursor Processing.
  104. V Oliveira, 2001, Substrate specificity characterization of recombinant metallo oligo-peptidases thimet oligopeptidase and neurolysin, Biochemistry, 40, 4417, 10.1021/bi002715k · DOI
  105. F Tholander, 2008, Structure-based dissection of the active site chemistry of leukotriene A4 hydrolase: implications for M1 aminopeptidases and inhibitor design, Chem Biol, 15, 920, 10.1016/j.chembiol.2008.07.018 · DOI
  106. RJ Ganji, 2015, Structural basis for the inhibition of M1 family aminopeptidases by the natural product actinonin: Crystal structure in complex with E. coli aminopeptidase N, Protein Science, 24, 823, 10.1002/pro.2653 · DOI
  107. E Lindahl, 2006, NOMAD-Ref: visualization, deformation and refinement of macromolecular structures based on all-atom normal mode analysis, Nucleic Acids Research, 34, W52, 10.1093/nar/gkl082 · DOI
  108. R Reddi, 2020, Puromycin, a selective inhibitor of PSA acts as a substrate for other M1 family aminopeptidases: Biochemical and structural basis, Int J Biol Macromol, 165, 1373, 10.1016/j.ijbiomac.2020.10.035 · DOI
  109. SA Combs, 2013, Small-molecule ligand docking into comparative models with Rosetta, Nature protocols, 8, 1277, 10.1038/nprot.2013.074 · DOI
  110. S DeLuca, 2015, Fully Flexible Docking of Medium Sized Ligand Libraries with RosettaLigand., PLoS One., 10, e0132508, 10.1371/journal.pone.0132508 · DOI
  111. S Lyskov, 2013, Serverification of molecular modeling applications: the Rosetta Online Server that Includes Everyone (ROSIE)., PLoS One, 8, e63906, 10.1371/journal.pone.0063906 · DOI
  112. T Kabuta, 2006, Degradation of amyotrophic lateral sclerosis-linked mutant Cu,Zn-superoxide dismutase proteins by macroautophagy and the proteasome, Journal of Biologial Chemistry, 281, 30524, 10.1074/jbc.M603337200 · DOI
  113. AR Tobler, 1997, Cloning of the human puromycin-sensitive aminopeptidase and evidence for expression in neurons, J Neurochem, 68, 889, 10.1046/j.1471-4159.1997.68030889.x · DOI

Metadata

Authors
Madabushi, S., Chow, K. M., Song, E. S., Goswami, A., Hersh, L. B., & Rodgers, D. W.
Affiliations
University of Kentucky (US)
Corresponding author
Rodgers, David W.
Venue
PLOS ONE
Published
2023-07-13
Volume
18
Issue
7
Pages
e0287086
ISSN
1932-6203 (ISSN-L)
OpenAlex
W4384156328
Cited by
9
References
4
Citations by year
2026: 2 · 2025: 4 · 2024: 3
FWCI
0.66
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institute of General Medical Sciences (GM130954)
  • National Institute of Neurological Disorders and Stroke (NS38041)
  • National Institute on Drug Abuse (DA02243)
  • National Science Foundation (IIA-1355438)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
Keywords
puromycin-sensitive aminopeptidase, zinc metallopeptidase, crystal structure, microtubule binding, substrate recognition, S1 subsite, active site, peptide degradation
MeSH terms
Aminopeptidases, Binding Sites, Peptides, Substrate Specificity, Metalloproteases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review